Takako Eguchi-Nakajima

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi et al. · Annals of Oncology · 2017 · 576 citations · Full text

Phase I Study of NK012, a Novel SN-38–Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors

Tetsuya Hamaguchi, Toshihiko Doi, Takako Eguchi-Nakajima et al. · Clinical Cancer Research · 2010 · 144 citations

Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine

Makiko Ono, Kuniaki Shirao, Atsuo Takashima et al. · Gastric Cancer · 2008 · 21 citations

Combination Chemotherapy, Gastrointestinal Oncology, Small Intestine +8

Genetic Polymorphisms of Copper-and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients

Hiromi Fukushima‐Uesaka, Yoshiro Saito, Keiko Maekawa et al. · Drug Metabolism and Pharmacokinetics · 2009 · 16 citations

Rationale and design of the TRUSTY study: a randomised, multicentre, open-label phase II/III study of trifluridine/tipiracil plus bevacizumab versus irinotecan, fluoropyrimidine plus bevacizumab as second-line treatment in patients with metastatic colorectal cancer progressive during or following first-line oxaliplatin-based chemotherapy

Takayuki Yoshino, Eiji Oki, Hiroaki Nozawa et al. · ESMO Open · 2018 · 15 citations · Full text